This file is part of IDEAS , which uses RePEc data
[ Papers |
Articles |
Software |
Books |
Chapters |
Authors |
Institutions |
JEL Classification |
NEP reports |
Search |
New papers by email |
Author registration |
Rankings |
Volunteers |
FAQ |
Blog |
Help! ]
John Wiley & Sons, Ltd. Health Economics Contact information of
John Wiley & Sons, Ltd.: http://www3.interscience.wiley.com/cgi-bin/jhome/5749 Pricing
information: individual rates available on request Editor: Editor: Editor:
For technical questions regarding this series, please contact
(Christopher F. Baum) Series handle: repec:wly:hlthec
More pages of listings: 0 |1 |2 |3 |4 |5 2008, Volume 17, Issue S1
2008, Volume 17, Issue 7 2008, Volume 17, Issue 6 2008, Volume 17, Issue 5 2008, Volume 17, Issue 4 2008, Volume 17, Issue 3 2008, Volume 17, Issue 2 2008, Volume 17, Issue 1 2007, Volume 28, Issue 4-5 229-229 Editorial by John A. Vernon & Richard L Manning [Downloadable!]
231-250 Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion by Ernst R. Berndt & Patricia M. Danzon & Gregory B. Kruse [Downloadable!]
251-265 'Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets by David Reiffen & Michael R. Ward [Downloadable!]
267-283 Uncertainty and choice: the challenges of pharmaceutical efficacy, safety, and cost by F.M. Scherer [Downloadable!]
285-291 Commentary by Joseph A. DiMasi [Downloadable!]
293-306 The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions by Thomas A. Abbott & John A. Vernon [Downloadable!]
307-328 Mergers and acquisitions in the pharmaceutical and biotech industries by Patricia M. Danzon & Andrew Epstein & Sean Nicholson [Downloadable!]
329-351 Effects of profit-reducing policies on firm survival, financial performance, and new drug introductions in the research-based pharmaceutical industry by Darren Filson & Neal Masia [Downloadable!]
353-355 Commentary by Joseph Golec [Downloadable!]
357-370 Determinants of drug prices and expenditures by William S. Comanor & Stuart O. Schweitzer [Downloadable!]
371-392 Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health' by Frank R. Lichtenberg & Suchin Virabhak [Downloadable!]
393-405 An industrial organization perspective on the influenza vaccine shortage by F.M. Scherer [Downloadable!]
407-413 Drug and vaccine pricing and innovation: what is the story? by Mark V. Pauly [Downloadable!]
415-435 A primer on the economics of re-importation of prescription drugs by Ernst R. Berndt [Downloadable!]
437-438 Commentary by Tomas J. Philipson [Downloadable!]
439-451 Entry and competition in generic biologics by Henry G. Grabowski & David B. Ridley & Kevin A. Schulman [Downloadable!]
453-454 Commentary by Tomas J. Philipson [Downloadable!]
455-465 Product differentiation, competition and regulation of new drugs: the case of statins in four European countries by Panos Kanavos & Joan Costa Font & Alistair McGuire [Downloadable!]
467-468 Commentary by Tomas J. Philipson [Downloadable!]
469-479 The cost of biopharmaceutical R&D: is biotech different? by Joseph A. DiMasi & Henry G. Grabowski [Downloadable!]
481-483 New estimates of pharmaceutical research and development spending by US-based firms from 1984 to 2003 by Joseph Golec & John A. Vernon [Downloadable!]
485-490 Benefits and costs of newer drugs: an update by Frank R. Lichtenberg [Downloadable!]
491-502 Generic competition and market exclusivity periods in pharmaceuticals by Henry G. Grabowski & Margaret Kyle [Downloadable!]
503-507 The role of different types of health insurance on access and utilization: comparative results on two chronic conditions (hypertension and diabetes type II without complication) by Christine Huttin [Downloadable!]
509-520 Rx Roulette: combatting counterfeit pharmaceuticals in developing nations by Kristina M. Lybecker [Downloadable!]
521-522 The truth about the drug companies, by Marcia Angell, Random House: New York, 2004. xx +305 pp., $24.95 by F.M. Scherer [Downloadable!]
2007, Volume 16, Issue 12 2007, Volume 16, Issue 11 2007, Volume 16, Issue 10 2007, Volume 16, Issue 9 2007, Volume 16, Issue 8 2007, Volume 16, Issue 7 2007, Volume 16, Issue 6 2007, Volume 16, Issue 5 2007, Volume 16, Issue 4 2007, Volume 16, Issue 3 2007, Volume 16, Issue 2 2007, Volume 16, Issue 1 2006, Volume 15, Issue 12 0 |1 |2 |3 |4 |5 Access
and download statistics
Did you know? IDEAS also covers the most complete directory of Economics departments and institutes, EDIRC .
This page was last updated on 2008-7-8.
IDEAS at the Department of Economics , College of Liberal Arts and Sciences , University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics .